See Things Differently
Clareon® Vivity® Extended Depth of Focus
Expand what’s possible with the first and only non-diffractive presbyopia-correcting EDOF1,2*
Clareon® Vivity® Extended Vision IOL
Expand what’s possible: the first and only non-diffractive presbyopia-mitigating IOL with exceptional clarity1,2*
Provide patients with excellent distance, intermediate and functional near vision with a monofocal IOL visual disturbance profile.1†
By harnessing the power of non-diffractive X-WAVE™ Technology, the Clareon® Vivity® IOL helps your patients take advantage of enhanced vision where they need it most.
Monofocal-quality
distance vision
Binocular Mean Uncorrected Distance Visual Acuity1†‡
20/20
Excellent intermediate
vision
Binocular Mean Uncorrected Intermediate Visual Acuity (26 in)1†
>20/25
Functional near
vision
Binocular Mean Uncorrected Near Visual Acuity (16 in)1†‡
20/32
Low levels of patient reported visual disturbances1†§‖
* Based on in vitro examinations of glistenings, surface haze and SSNGs.
† Results from a prospective, randomized, parallel group, subject- and assessor-masked, multisite trial of 107 subjects bilaterally implanted with the AcrySof® IQ Vivity® IOL and 113 with the AcrySof® IQ IOL with 6 months follow-up.
‡ Snellen VA was converted from logMAR VA. A Snellen notation of 20/20-2 or better indicates a logMAR VA of 0.04 or better, which means 3 or more of the 5 ETDRS chart letters in the line were identified correctly.
§ Assessed using QUVID questionnaire.
‖ AcrySof® IQ Vivity® was tested. AcrySof® IQ Vivity® and Clareon® Vivity® are optically equivalent.
Hear what surgeons are saying about the Clareon® Vivity® IOL
Explore additional resources for Clareon® Vivity® IOLs
Non-diffractive X-WAVE™ Technology
This proprietary technology features two smooth surface transition elements that simultaneously stretch and shift light without splitting it.1,3,4
Strong patient satisfaction demonstrated in clinical studies
90%
of patients were satisfied with their results and would get the Clareon® Vivity® IOL again.5†||¶
93%
of patients would recommend the Clareon® Vivity® IOL to a friend or family member.5†||¶
† Results from a prospective, randomized, parallel group, subject- and assessor-masked, multisite trial of 107 subjects bilaterally implanted with the AcrySof® IQ Vivity® IOL and 113 with the AcrySof® IQ IOL with 6 months follow-up.
‖ AcrySof® IQ Vivity® was tested. AcrySof® IQ Vivity® and Clareon® Vivity® are optically equivalent.
¶ Response to the following question in IOLSAT questionnaire at 6 months post-op: “Given your vision today, if you had to do it all over, would you have the same lens implanted again?”
Hear about the impact the Clareon® Vivity® IOL is having on patients
Share our product brochure with your patients to communicate the Clareon® difference
Available on Clareon®: Alcon’s most advanced IOL biomaterial to date
IMPORTANT PRODUCT INFORMATION - CLAREON® ASPHERIC FAMILY OF HYDROPHOBIC ACRYLIC IOLS
The Clareon® Vivity® Extended Vision Hydrophobic Posterior Chamber IOLs include Clareon® Vivity® and Clareon® Vivity® Toric IOLs and are intended for primary implantation for the visual correction of aphakia in adult patients with <1.00 D of preoperative corneal astigmatism, in whom a cataractous lens has been removed by extracapsular cataract extraction. The lens mitigates the effects of presbyopia by providing an extended depth of focus. Compared to an aspheric monofocal IOL, the lens provides improved intermediate and near visual acuity, while maintaining comparable distance visual acuity. The Clareon® Vivity® IOL is intended for capsular bag placement only. In addition, the Clareon® Vivity® Toric IOL is indicated for the reduction of residual refractive astigmatism in adult patients with pre-existing corneal astigmatism.
Refer to the eDirections for Use for more information regarding indications, contraindications, warnings, precautions, and cautions.
REFERENCES:
- Clareon® Vivity® Extended Vision Hydrophobic IOL (CNWET0) Directions for Use – USA.
- Werner L, Thatthamla I, Ong M, et al. Evaluation of clarity characteristics in a new hydrophobic acrylic IOL. J Cataract Refract Surg. 2019;45:1490-1497.
- Alcon Data on File, 2019.
- Alcon Data on File, 2019.
- Alcon Data on File, 2019.
